Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors

Wake Forest University (WFU)

Status: Completed

Conditions: Endometrial Cancer; Survivorship

Treatments: Other: Survey; Other: Interview Regarding Heart Health; Other: PREVENT Cardiovascular Health Assessment Tool

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05796518

P30CA012197 (U.S. NIH Grant/Contract)

WFBCCC 99123 (Other Identifier)

IRB00095005

Details and patient eligibility

About

Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.

Full description

Primary Objective: The primary objective of this pilot study is to assess the feasibility of enrolling and completing the heart health assessment among endometrial cancer patients scheduled for routine follow-up care.

Secondary Objectives:

• To assess patient satisfaction with the tool.
• To identify the proportion of patients with non-ideal cardiovascular health scores who report initiating discussions regarding cardiovascular health during their routine oncology appointment.

Enrollment: 44 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Scheduled for a routine surveillance visit for pathologically confirmed stages I-IV endometrial cancer
• Greater than or equal to 3 months post-potentially curative cancer treatment
• Patients must be at least 18 years of age
• Have a working email address
• Comfortable reading medical information in English, as per self-report

Exclusion criteria

• Currently receiving treatment (e.g. radiation, chemotherapy, immunological treatments for endometrial cancer)
• Have a history of endometrial cancer recurrence
• Enrolled in hospice care or documentation of life expectancy < 6 months

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

44 participants in 1 patient group

PREVENT - Cardiovascular Health Assessment Tool

Experimental group

Description:

An adapted version of the PREVENT tool for endometrial cancer survivors will be used collect data during routine follow-up care for endometrial cancer that will yield a cardiovascular health score based on the Simple 7 risk factors (current smoking habits, body mass index, physical activity, diet, cholesterol, blood pressure and fasting plasma glucose).

Treatment:

Other: Interview Regarding Heart Health

Other: PREVENT Cardiovascular Health Assessment Tool

Other: Survey